diabetes glp-1 agonist Mechanisms of action of GLP-1RA Trends in the Development of
Description
The liver does not biotransform it
And yeah, sometimes that requires a pharmaceutical 'cause it's better than heart surgery when we start looking at the tier of med medical interventions, right
Two randomized control clinical trials reported conflicting effects on bone mineral content (BMC) and bone mineral density (BMD): one trial demonstrated preservation of BMC with GLP-1 use, while the other found no significant difference in BMC or BMD between treatment and control groups
Al-Karadsheh, T
Nauck MA, Meininger G, Sheng D, et al
